Breast cancer after a negative screen: follow-up of women participating in the DOM Screening Programme.
暂无分享,去创建一个
C Collette | H. Collette | J. Fracheboud | J Fracheboud | H J Collette | F de Waard | C. Collette | C T Brekelmans | C. Brekelmans | F. de Waard | C. Brekelmans | Corinne Collette | Frits de Waard
[1] M Moskowitz,et al. Breast cancer: age-specific growth rates and screening strategies. , 1986, Radiology.
[2] J. Hendriks,et al. MAMMOGRAPHIC SCREENING AND BREAST CANCER MORTALITY: AGE-SPECIFIC EFFECTS IN NIJMEGEN PROJECT, 1975-82 , 1985, The Lancet.
[3] N E Day,et al. Estimating the sensitivity of a screening test. , 1985, Journal of epidemiology and community health.
[4] R. Greenberg,et al. Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening. , 1986, Cancer research.
[5] R Holland,et al. The occurrence of interval cancers in the Nijmegen screening programme. , 1989, British Journal of Cancer.
[6] L. Tabár,et al. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. , 1987, British Journal of Cancer.
[7] L. Tabár,et al. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. , 1989, Journal of epidemiology and community health.
[8] N. Day,et al. EVALUATION OF SCREENING FOR BREAST CANCER IN A NON-RANDOMISED STUDY (THE DOM PROJECT) BY MEANS OF A CASE-CONTROL STUDY , 1984, The Lancet.
[9] E. A. Baanders-van Halewijn,et al. The DOM project for the early detection of breast cancer, Utrecht, The Netherlands. , 1984, Journal of chronic diseases.
[10] S D Walter,et al. Estimation of the duration of a pre-clinical disease state using screening data. , 1983, American journal of epidemiology.
[11] L. Tabár,et al. REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985, The Lancet.